Related Experiment Video
Updated: May 25, 2026

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
Published on: April 3, 2015
Vascular graft infections
Olivier Leroy1, Agnès Meybeck, Béatrice Sarraz-Bournet
1Service de Réanimation et Maladies Infectieuses, CHRU, Lille, France. oleroy@ch-tourcoing.fr
Purpose Of Review:
This review provides a focus on infections of prosthetic vascular grafts used to treat peripheral arterial diseases.
Recent Findings:
The incidence of infections varies between 1 and 6%. Risk factors of infection are not well identified. Main causative pathogens are Gram-negative bacilli, Staphylococcus aureus, and coagulase-negative staphylococci, without clear differences according to location of graft and time of onset of infection. There is no consensual diagnostic criterion. The basic principles for management of graft infections have been known for many years. A surgical approach combining graft excision, complete debridement, and maintaining distal vascular flow is required. Antimicrobial therapy is always instituted to reduce sepsis and prevent secondary graft infection, but there are no evidence-based data to recommend any regimen. However, antibiotics should have bactericidal activity whatever the bacteria growth phase, reduce the microbial burden, penetrate within the biofilm, and prevent further biofilm formation. Mortality and morbidity from these infections remain significant.
Summary:
A multidisciplinary approach with a limited number of reference centres, recruiting sufficient numbers of patients to perform controlled trials, and to provide expert recommendations, could be the best way to answer unresolved questions and improve the prognosis.
Insights
Infections of prosthetic vascular grafts for peripheral arterial disease occur in 1-6% of cases. Management requires surgery and antibiotics, but optimal strategies and risk factors remain unclear, leading to significant morbidity.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Biomaterials
Background:
- Prosthetic vascular grafts are crucial for treating peripheral arterial diseases.
- Graft infections represent a serious complication with significant morbidity and mortality.
- Current understanding of risk factors and optimal management strategies is limited.
Purpose of the Study:
- To review current knowledge on prosthetic vascular graft infections.
- To identify causative pathogens and discuss diagnostic challenges.
- To outline current management principles and highlight areas for future research.
Main Methods:
- Literature review focusing on prosthetic vascular graft infections.
- Analysis of incidence, risk factors, pathogens, diagnostics, and management.
- Synthesis of current evidence and expert recommendations.
Main Results:
- Incidence of infection ranges from 1% to 6%.
- Common pathogens include Gram-negative bacilli and Staphylococci; risk factors are poorly defined.
- Surgical intervention (excision, debridement, maintaining flow) and antimicrobial therapy are essential, though evidence-based regimens are lacking.
- Mortality and morbidity remain high.
Conclusions:
- A multidisciplinary approach is recommended for managing graft infections.
- Establishing reference centers for controlled trials is necessary to address unresolved questions.
- Improving patient outcomes requires further research and standardized expert recommendations.
Related Concept Videos
Hemodialysis I: Introduction
Aneurysm III: Interprofessional Care
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis

